POLAND 1921 SG157 GREEN 20M+30M RED FUND MH SURCHARGE Max 47% OFF OVERPRINT CROSS $10 POLAND 1921 SG157 GREEN 20M+30M RED CROSS FUND OVERPRINT SURCHARGE MH Stamps Europe Poland $10 POLAND 1921 SG157 GREEN 20M+30M RED CROSS FUND OVERPRINT SURCHARGE MH Stamps Europe Poland 20M+30M,SG157,Stamps , Europe , Poland,POLAND,RED,musicalrealism.com,GREEN,CROSS,1921,/forenoted1577784.html,SURCHARGE,FUND,$10,MH,OVERPRINT POLAND 1921 SG157 GREEN 20M+30M RED FUND MH SURCHARGE Max 47% OFF OVERPRINT CROSS 20M+30M,SG157,Stamps , Europe , Poland,POLAND,RED,musicalrealism.com,GREEN,CROSS,1921,/forenoted1577784.html,SURCHARGE,FUND,$10,MH,OVERPRINT
POLAND 1921 SG157 GREEN 20M+30M RED CROSS FUND OVERPRINT SURCHARGE MH
$10
POLAND 1921 SG157 GREEN 20M+30M RED CROSS FUND OVERPRINT SURCHARGE MH
|||
Item specifics
Denomination:
20m+30m
Type:
Postage
Year of Issue:
1921
Country/Region of Origin:
Poland
Quality:
Mint Hinged
Grade:
VG (Very Good)
Topic:
Red Cross
Colour:
Green
POLAND 1921 SG157 GREEN 20M+30M RED CROSS FUND OVERPRINT SURCHARGE MH
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 12th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Mycoses spring in every nook and cranny. It is not only a…
With its newly developed software platform “EUROLabPolaris” EUROIMMUN meets the demands in the increasingly globalised field of laboratory diagnostics by enabling large laboratory groups to work together on digitally-supported immunofluorescence diagnostics across several sites. In an interview Timo Schütze, the…
With the Corporate COVID-19 Antibody Testing Program, EUROIMMUN gives companies the possibility to offer to their staff what EUROIMMUN has already offered to th…
Guest contribution:Article series on the subject of state-of-the-art mycology in dermatology, 11th articleby Prof Hans-Jürgen Tietz, Director of the Institute…
Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rap…
Traditionally, Christmas is the time to reflect on what you have achieved and to turn your attention to those who are less well off.After the very challenging,…
For several weeks PerkinElmer, Inc. has been collecting nominations for a variety of Global Innovation Awards across all companies of the Group. EUROIMMUN has a…
In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management…
It is becoming increasingly clear that not only antibodies against SARS-CoV-2 play a role in building immunity against the coronavirus. T cells, as part of t…
We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics co…
Always the perfect match for the automation of your lab routineEUROIMMUN has been building expertise in immunofluorescence diagnostics since the 1980s. The indi…
Since end of 2020, different SARS-CoV-2 variants have appeared worldwide − alpha (B.1.1.7), beta (B.1.351), gamma (P.1/B.1.1.128) and delta (B1.617.2) − whi…
Six months after the start of the COVID-19 vaccination campaign in Germany, half of the population has received at least one vaccination dose. According to the…
Press ReleaseNovel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progressionEUROIMMUN, a…
Anti-SARS-CoV-2 antibody standard preparation from the WHO now availableSince end of December 2020, the first international reference material, “First WHO Int…
Guest contribution:Article series on the subject of state-of-the-art mycology in dermatology, 12th articleby Prof Hans-Jürgen Tietz, Director of the Institute…
